CSafe launches temperature-controlled packaging for cell therapies

By Vassia Barba contact

- Last updated on GMT

(Image: Getty/ismagilov)
(Image: Getty/ismagilov)

Related tags: CSafe, Packaging, Supply chain, Cold chain, Logistics, cell and gene therapy

CSafe expands its cold chain offering with a series of logistics services suitable for temperature-controlled shipping of biologics.

The set of services, known as AcuTemp Plus, is expected to meet an increased demand for temperature-controlled shipments due to the specific needs for the preservation of biologics, including cell and gene therapies, CSafe stated.

AcuTemp Plus packaging is designed to maintain the preferable internal temperature of the shipment, by utilizing CSafe’s ThermoCor Vacuum Insulated Panels. The packaging system is available in several sizes and temperature profiles.

Moreover, along with AcuTemp, the client is provided with different track and trace options to monitor the shipment – as well as the company’s retest and reuse program, known as Repaq, which allows clients to have their shipping boxes inspected, cleaned, and thermally requalified, in order to reuse them for the next shipments.

According to the company’s CEO, Patrick Schafer, during tests, the reusable packaging technology presented temperature control capabilities that outlast similar products available on the market ‘by a large margin’.

In October 2019, the company signed an agreement with LOT Cargo​, forming an ‘essential’ partnership to ensure continuance of the cold-chain logistics services for biologics, Shea Vincent, the company’s global product manager told us at the time.

Related news

Show more

Related products

Why Blister Packaging: Things to Consider

Why Blister Packaging: Things to Consider

Catalent Pharma Solutions | 03-Dec-2020 | Insight Guide

The decision to use blister packaging for either clinical trials or commercial drug manufacturing comes with a host of factors to consider. Pharmaceutical...

Lessons Learned: Clinical Trials During a Pandemic

Lessons Learned: Clinical Trials During a Pandemic

PCM TRIALS | 01-Sep-2020 | Technical / White Paper

In a recent survey of clinical trial professionals (including pharmaceutical sponsors, CROs, site representatives and vendors), respondents reported that...

Manufacturing Cyto and Non-Cyto Drugs in One Facility

Manufacturing Cyto and Non-Cyto Drugs in One Facility

Baxter BioPharma Solutions | 01-Mar-2020 | Technical / White Paper

Recent market reports suggest increasing product niches, which may lead to decreasing numbers of units per product, making dedicated facilities less practical....

Related suppliers

Follow us


View more